Pavone L - Search Results

1

Prognostic significance of albuminuria in patients with renal cell cancer.

Vaglio A, Buzio L, Cravedi P, Pavone L, Garini G, Buzio C. Vaglio A, et al. Among authors: pavone l. J Urol. 2003 Oct;170(4 Pt 1):1135-7. doi: 10.1097/01.ju.0000085984.90991.9a. J Urol. 2003. PMID: 14501709

2

"Late" regressions of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimen.

Giacosa R, Santi R, Vaglio A, Pavone L, Ferrozzi F, Passalacqua R, Buzio C. Giacosa R, et al. Among authors: pavone l. Acta Biomed. 2004 Aug;75(2):126-30. Acta Biomed. 2004. PMID: 15481703

3

Long-term immunotherapy with low-dose interleukin-2 and interferon-alpha in the treatment of patients with advanced renal cell carcinoma.

Buzio C, Andrulli S, Santi R, Pavone L, Passalacqua R, Potenzoni D, Ferrozzi F, Giacosa R, Vaglio A. Buzio C, et al. Among authors: pavone l. Cancer. 2001 Nov 1;92(9):2286-96. doi: 10.1002/1097-0142(20011101)92:9<2286::aid-cncr1575>3.0.co;2-i. Cancer. 2001. PMID: 11745283 Clinical Trial.

4

Long-term treatment with low doses of interleukin-2 and interferon-alpha: immunological effects in advanced renal cell cancer.

Pavone L, Andrulli S, Santi R, Majori M, Buzio C. Pavone L, et al. Cancer Immunol Immunother. 2001 Apr;50(2):82-6. doi: 10.1007/s002620100175. Cancer Immunol Immunother. 2001. PMID: 11401029 Free PMC article.

5

Natural killer cell cytotoxicity is enhanced by very low doses of rIL-2 and rIFN-alpha in patients with renal cell carcinoma.

Pavone L, Fanti G, Bongiovanni C, Goldoni M, Alberici F, Bonomini S, Cristinelli L, Buzio C. Pavone L, et al. Med Oncol. 2009;26(1):38-44. doi: 10.1007/s12032-008-9078-7. Epub 2008 May 31. Med Oncol. 2009. PMID: 18516705

6

Outcome and prognostic factors during the course of primary small-vessel vasculitides.

Pavone L, Grasselli C, Chierici E, Maggiore U, Garini G, Ronda N, Manganelli P, Pesci A, Rioda WT, Tumiati B, Pavesi G, Vaglio A, Buzio C; Secondary and Primar Vasculitides (Se.Pri.Va) Study Group. Pavone L, et al. J Rheumatol. 2006 Jul;33(7):1299-306. Epub 2006 Jun 15. J Rheumatol. 2006. PMID: 16783858

7

Cardiac involvement in the Churg-Strauss syndrome.

Pelà G, Tirabassi G, Pattoneri P, Pavone L, Garini G, Bruschi G. Pelà G, et al. Among authors: pavone l. Am J Cardiol. 2006 May 15;97(10):1519-24. doi: 10.1016/j.amjcard.2005.11.088. Epub 2006 Mar 31. Am J Cardiol. 2006. PMID: 16679097

8

Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.

Maritati F, Alberici F, Oliva E, Urban ML, Palmisano A, Santarsia F, Andrulli S, Pavone L, Pesci A, Grasselli C, Santi R, Tumiati B, Manenti L, Buzio C, Vaglio A. Maritati F, et al. Among authors: pavone l. PLoS One. 2017 Oct 10;12(10):e0185880. doi: 10.1371/journal.pone.0185880. eCollection 2017. PLoS One. 2017. PMID: 29016646 Free PMC article. Clinical Trial.

9

Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.

Sinico RA, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C, Grasselli C, Pavone L, Gregorini G, Monti S, Frassi M, Vecchio F, Corace C, Venegoni E, Buzio C. Sinico RA, et al. Among authors: pavone l. Arthritis Rheum. 2005 Sep;52(9):2926-35. doi: 10.1002/art.21250. Arthritis Rheum. 2005. PMID: 16142760 Free article.

10

Respiratory system involvement in ANCA-associated systemic vasculitides.

Pesci A, Pavone L, Buzio C, Manganelli P. Pesci A, et al. Among authors: pavone l. Sarcoidosis Vasc Diffuse Lung Dis. 2005 Dec;22 Suppl 1:S40-8. Sarcoidosis Vasc Diffuse Lung Dis. 2005. PMID: 16457016 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters